RWA Wealth Partners’s Quest Diagnostics DGX Stock Holding History

RWA Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,316	Closed	-$264K	–	215
2020 Q2	$264K	Buy	+2,316	New	+$246K	0.03%	184
2020 Q1	–	Sell	-2,316	Closed	-$247K	–	209
2019 Q4	$247K	Hold	2,316	–	–	0.02%	214
2019 Q3	$248K	Hold	2,316	–	–	0.03%	209
2019 Q2	$236K	Hold	2,316	–	–	0.03%	203
2019 Q1	$208K	Buy	+2,316	New	+$201K	0.02%	218
2018 Q4	–	Sell	-2,369	Closed	-$256K	–	227
2018 Q3	$256K	Hold	2,369	–	–	0.03%	197
2018 Q2	$260K	Hold	2,369	–	–	0.03%	206
2018 Q1	$238K	Sell	2,369 -49	-2%	-$5.02K	0.03%	181
2017 Q4	$238K	Buy	2,418 +102	+4%	+$9.67K	0.03%	212
2017 Q3	$217K	Buy	+2,316	New	+$246K	0.02%	221

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RWA Wealth Partners's DGX Position: Q3 2020 in Review

RWA Wealth Partners sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 2,316 shares — an estimated $264K sold.

RWA Wealth Partners first reported a position in DGX in Q3 2017 and held it in 10 quarters. The position peaked at $264K in Q2 2020. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

RWA Wealth Partners reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
RWA Wealth Partners sold 2,316 Quest Diagnostics shares in Q3 2020, an estimated $264K.
RWA Wealth Partners first reported a position in Quest Diagnostics in Q3 2017 and held it in 10 quarters.
RWA Wealth Partners's Quest Diagnostics position peaked at $264K in Q2 2020.
757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on RWA Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.